GLP-1 RECEPTOR AGONI STS AND DR Considerations for when your patient starts treatment with this type of medication for type 2 diabetes.
Publication
, Journal Article
Kapoor, I; Hadziahmetovic, M
Published in: Retina Today
May 1, 2024
Duke Scholars
Published In
Retina Today
EISSN
1825-0572
Publication Date
May 1, 2024
Volume
2024-May-June
Start / End Page
17 / 18
Citation
APA
Chicago
ICMJE
MLA
NLM
Kapoor, I., & Hadziahmetovic, M. (2024). GLP-1 RECEPTOR AGONI STS AND DR Considerations for when your patient starts treatment with this type of medication for type 2 diabetes. Retina Today, 2024-May-June, 17–18.
Kapoor, I., and M. Hadziahmetovic. “GLP-1 RECEPTOR AGONI STS AND DR Considerations for when your patient starts treatment with this type of medication for type 2 diabetes.” Retina Today 2024-May-June (May 1, 2024): 17–18.
Kapoor I, Hadziahmetovic M. GLP-1 RECEPTOR AGONI STS AND DR Considerations for when your patient starts treatment with this type of medication for type 2 diabetes. Retina Today. 2024 May 1;2024-May-June:17–8.
Kapoor, I., and M. Hadziahmetovic. “GLP-1 RECEPTOR AGONI STS AND DR Considerations for when your patient starts treatment with this type of medication for type 2 diabetes.” Retina Today, vol. 2024-May-June, May 2024, pp. 17–18.
Kapoor I, Hadziahmetovic M. GLP-1 RECEPTOR AGONI STS AND DR Considerations for when your patient starts treatment with this type of medication for type 2 diabetes. Retina Today. 2024 May 1;2024-May-June:17–18.
Published In
Retina Today
EISSN
1825-0572
Publication Date
May 1, 2024
Volume
2024-May-June
Start / End Page
17 / 18